BarreJ., HouinG., TillementJ.P.: Dose-dependent pharmacokinetic study of pefloxacin, a new antibacterial agent, in humans. J. Pharm. Sc, 73; 1379–1382 (1984).
SinglasE., TaburetA.M.: Pharmacocinétique clinique des nouvelles quinolones. Nouv. Quinolones, p. 83–102, Arnette ed., Paris 1985.
7.
ThabautA., MeyranM.: Activité bactericide in vitro des nouvelles quinolones seules et en associations. Nouv. Quinolones, p. 45–71, Arnette ed., Paris1985.
8.
TizzaniA., CasettaG., PianaP., SegoloniG., EanaiM., BraggioN., ResegottiL., VentrigliaG., NejrottiM.: Problemi di nefrologia e urologia. S.I.M.G., 3; 5–54 (1986).
9.
WolffM., VittecoqD., RegnierB., ModaiJ., VachonF., SarrazinC., BureA.: Preliminary trial of pefloxacin in the treatment of urinary tract infections and seriously ill patients treated in hospital. Abst. P.S. 4-6, 4-14, XIII Intern. Congr. Chemoth., Vienna 1983.